8,528
Total Claims
$2.8M
Drug Cost
778
Beneficiaries
$3,589
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-91%
Opioid rate vs peers
0.2% vs 2.6% avg
+236%
Cost per patient vs peers
$3,589 vs $1,068 avg
+228%
Brand preference vs peers
29.5% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
19
Opioid Claims
$273
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
71% generic
Brand: 2,474 claims · $2.6M
Generic: 5,915 claims · $152K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 398 | $634K |
| Tirzepatide | 181 | $231K |
| Empagliflozin/Metformin Hcl | 133 | $193K |
| Dapaglifloz Propaned/Metformin | 121 | $139K |
| Empagliflozin | 79 | $117K |
| Semaglutide | 52 | $81K |
| Insulin Glargine/Lixisenatide | 54 | $71K |
| Finerenone | 35 | $68K |
| Dapagliflozin Propanediol | 56 | $59K |
| Apixaban | 46 | $57K |
| Sitagliptin Phos/Metformin Hcl | 38 | $55K |
| Insulin Degludec | 45 | $51K |
| Evolocumab | 50 | $49K |
| Bictegrav/Emtricit/Tenofov Ala | 11 | $44K |
| Dulaglutide | 28 | $41K |
Prescribing Profile
Patient Profile
74
Avg Age
49%
Female
1.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About